DIACOMIT is the only FDA-approved antiseizure medication specifically for seizures associated with Dravet syndrome in children as young as 6 months. It is indicated for patients weighing 15 pounds or more and taking clobazam.
DIACOMIT® (stiripentol) helps patients achieve profound seizure reduction so families can celebrate everyday wins.1,6
DIACOMIT is an FDA-approved antiseizure medication developed specifically to treat seizures associated with Dravet syndrome in children 6 months and older (weighing 15 lb or more) taking clobazam.
We know that finding the right combination of antiseizure treatments for your child is critical. With DIACOMIT (stiripentol), profound seizure reduction is possible. Treatment can be initiated as early as 6 months. Results may vary.
DIACOMIT is proven to significantly reduce generalized clonic or tonic clonic seizures. 1,6-8Review the Research
DIACOMIT is available in different forms and doses to fit your child’s unique needs.Get Started
Biocodex is By Your Side, making it easier than ever to fill a prescription for DIACOMIT.Find Support